Market Research Logo

Malaysia Pharmaceuticals and Healthcare Report Q2 2016

Malaysia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: We hold a bullish outlook for Malaysia's pharmaceutical market over our forecast period. Webelieve the government's commitment to expanding healthcare access coupled with the country's growingpopulation and disease burden will drive medicine demand in the coming years. Furthermore, the signing ofthe Trans-Pacific Partnership (TPP) agreement - after years of negotiation and uncertainty - will work tostrengthen multinational interest in the market, particularly patented drug manufacturers.

Headline Expenditure Projections

Pharmaceuticals: MYR7.88bn (USD2.02bn) in 2015 to MYR8.59bn (USD2.05bn) in 2016; +9.0% inlocal currency and +1.4% in US dollar terms. Forecast unchanged from last quarter.

Healthcare: MYR45.85bn (USD11.73bn) in 2015 to MYR49.38bn (USD11.77bn) in 2016; +7.7% inlocal currency and +0.2% in US dollar terms. Forecast unchanged from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Malaysia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Malaysia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Malaysia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Malaysia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2012-2020)
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Malaysia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Malaysia 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Malaysia Risk/Reward Index
Rewards
Risks
Market Overview
Epidemiology
Healthcare Sector
Table: 2011 Entry Point Projects Summary
Table: Healthcare Resources (Malaysia 2010-2015)
Table: Healthcare Personnel (Malaysia 2010-2015)
Table: Healthcare Activity (Malaysia 2010-2015)
Healthcare Insurance
Table: Main Features Of 1Care
Healthcare Funding
Healthcare Sector Developments
Table: Public Sector And Private Sector Healthcare Developments
Medical Tourism
Research & Development
Clinical Trials
Regulatory Review
Regulatory Regime
Table: Drug Applications by Type, 2002-2010
Table: Registered Pharmaceutical Products by Type, 2002-2010
Regulatory Developments
Intellectual Property Issues
Pricing Regime
Competitive Landscape
Domestic Industry
Foreign Industry
Table: Table: Multinational Market Activity
Table: Leading Malaysian Pharmaceutical And Healthcare Companies
Culture-Specific Medicines
Pharmaceutical Distribution
Table: Drug Wholesalers & Importers, 2002-2010
Pharmaceutical Retail Sector
Company Profile
Chemical Company Of Malaysia
Kotra Pharma
Novartis
Ranbaxy Malaysia
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Malaysia 1990-2025)
Table: Key Population Ratios (Malaysia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Malaysia 1990-2025)
Table: Population By Age Group (Malaysia 1990-2025)
Table: Population By Age Group % (Malaysia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report